Treating zebrafish embryos with the anti-inflammatory drug Dexamethasone reverts the blood phenotype, suggesting anti-inflammatory treatment as an exciting future JMML-(like MPN) drug target at least in JMML patients with activating mutations in SHP2. This evidence concerns the gene PTPN11 and juvenile myelomonocytic leukemia.